Kemin Industries, alongside strategic shareholder Bpifrance, has invested €23 million in AFYREN to optimize and expand its biorefinery operations, reflecting strong confidence in sustainable innovation and market growth.
Target Company Information
AFYREN, a greentech company, specializes in providing biosourced and low-carbon products through its unique fermentation technology based on a completely circular model. The company has successfully developed a strong relationship with Kemin Industries since 2018, aiming to deploy innovative solutions at an industrial scale. Recently, AFYREN announced a capital increase, raising €23 million, fully subscribed by Kemin Industries and strategic shareholder Bpifrance, through its Large Venture fund.
The capital increase was priced at €2.40 per share, reflecting a 9% premium over the volume-weighted average price (VWAP) of AFYREN's shares over the three trading days prior to this pricing. This funding is intended for the optimization and expansion of AFYREN's NEOXY biorefinery to enhance production capacity and fulfill increasing market demand.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The biosourced and biotechnology sector in France is flourishing, supported by a strong push for sustainability and reduced carbon emissions. The French government, recognizing the importance of the bioeconomy, has implemen
Similar Deals
GENEO Capital Entrepreneur → MLab
2025
Bpifrance → Groupe Softway Medical
2025
Vivalto Santé → 3 establishments in France and 7 establishments in Europe
2024
Turenne Santé, Sodero → Vedalab
2024
Nord Est Partenaires, Carvest → HTC Santé
2024
Kemin Industries
invested in
AFYREN
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $23M